Clinical trial
Interventional Management of Stroke (IMS) III Trial
NCT00359424 · Joseph Broderick, Other · Terminated
Key facts
| NCT number | NCT00359424 |
|---|---|
| Title | Interventional Management of Stroke (IMS) III Trial |
| Official title | Interventional Management of Stroke Trial (IMS III): A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone |
| Acronym | IMSIII |
| Lead sponsor | Joseph Broderick, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH Medical University of South Carolina University of Calgary |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Stroke |
| Intervention type | Drug, Other |
| Interventions | IV rt-PA alone, endovascular therapy |
| Enrollment | 656 |
| Start date | Aug 1, 2006 |
| Primary completion | Jul 1, 2012 |
| Completion | Apr 1, 2013 |
| First posted | Aug 2, 2006 |
| Last update posted | Dec 13, 2013 |
| Countries | Australia, Canada, France, Germany, Netherlands, Spain, Switzerland, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: